MEDTEC UK Conference Programme - Wednesday, 13 February 2008 |
09.00 |
Registration
|
Chair: David Purcell
|
09.30 |
Chair’s Opening Address
|
09.45 |
Keynote Address: Current Issues with Clinical Evaluations: Jeremy Tinkler, Director of Regulatory Affairs, MedPass International
|
10.15 |
Break
|
| |
|
Session 100 - Regulation
|
Chair: David Purcell
|
10.40 |
Chair’s Opening Address
|
10.45 |
UK Position on Current Medical Device Issues: Mika Reinikainen, Managing Director, Abnovo Ltd
|
11.30 |
Revision of the Medical Devices Directive – An Industry Perspective: Dario Pirovano, Consultant, Director Regulatory Affairs, Eucomed
|
12.15 |
Revision of the New Approach and Consequent Effect on the Medical Device Legislation: Jos Putzeys, Manager, JKN Consult
|
13.00 |
Lunch
|
14.00 |
Re-use of Single Use Medical Devices: Peter Schroeer, Director Quality Systems and Regulatory Affairs, Ethicon Endo-Surgery (a Johnson and Johnson company)
|
14.45 |
Break
|
15.15 |
Revised Sterilisation Standards – What a Notified Body Expects To See For Validation Reports: Henry Sibun, Manager - Medical and Health Services, TÜV Product Service
|
16.00 |
Environmental Compliance for Medical Devices: Professor George Howarth, formerly Technical Director of Smith & Nephew Consumer Products and also Director of Group Environmental Affairs. Currently Chairman of the ABHI Environment Business Compliance Forum and Member of the EUCOMED Environmental Focus Group
|
16.45 |
Chair’s Closing Address
|
17.00 |
End of Session 100
|
|
Session 101 - Product Development and R&D
|
Chair: James Pink, Head of Business Development, BSI Global
|
10.40 |
Chair’s Opening Address
|
10.45 |
Opportunities and Issues around conducting Medical Device R&D in Europe: Sue Dunkerton, Director, Health Technologies Knowledge Transfer Network
|
11.30 |
Risk Management – Product, Process, Business: James Pink, Head of Business Development, BSI Global
|
12.30 |
Lunch
|
14.00 |
In-vitro Corrosion Testing of Medical Implants: Nigel Corlett, Managing Scientist, Exponent
|
14.45 |
Basic Principles in Biocompatibility Testing: Dr Gaëlle Clermont, Scientific Manager, Biomatech – NAMSA
|
15.30 |
Break
|
15.45 |
Design Transfer to Manufacturing: Richard Walker, Director, Quintiles Global Consulting
|
16.30 |
Turbo Charging Project Management of New Product Developments in R&D: Stephen Clegg, Senior Project Director, Medical Diagnostics, GE Project Management
|
17.15 |
Chair’s Closing Address
|
17.30 |
End of Day One
|
|
MEDTEC UK Conference Program – Thursday, 14 February 2008 |
Session 200 – Validation
|
Chair:
Eoin Barry, Managing Director, ARV Excellence
|
09.15 |
Chair’s Opening Address
|
09.30 |
Process Validation Master Planning: Eoin Barry, Managing Director, ARV Excellence
|
10.15 |
Clinical Evaluation – Meeting the EU Clinical Data Requirement for Medical Devices using the Literature Route: Danielle Giroud, Founder and CEO, D-Target
|
11.00 |
Break
|
11.15 |
Risks, Design and Validation Aspects in an Automated Production: Ulrika Siösteen, Solutions Director, Compliant Logistics
|
12.00 |
Software Validation - Understanding and Meeting the Requirements of the Revised Medical Devices Directive: Steve Grundy, Founder, Parachute Consultancy Services and Jed Place, Founder and Principal Consultant, Medical Device Technology Consultants
|
12.45 |
Lunch
|
14.00 |
Lean Product Development: Stewart Fox, Managing Consultant - Product and Process Engineering Practice, PA Consulting
|
14.45 |
Decreasing Product Release Times: Steven Walfish, President, Statistical Outsourcing Services
|
15.30 |
Break
|
15.45 |
CAPA: How to Measure System Effectiveness: Steven Walfish, President, Statistical Outsourcing Services
|
16.30 |
Chair's Closing Address
|
16.45 |
End of Session 200
|
Conference Registration Options and Fees
|
Before 12 January
|
| |
Reg Fee |
VAT |
Total |
| 1 day |
GBP 345.00 |
60.38 |
405.38 |
| 2 days |
GBP 581.63 |
86.63 |
581.63 |
After 12 January or on-site
|
| |
Reg Fee |
VAT |
Total |
| 1 day |
GBP 395.00 |
69.13 |
464.13 |
| 2 days |
GBP 595.00 |
104.13 |
699.13 |
| |
|
|
|
Conference registration includes admission to all sessions on registered day(s); visitor admission to exhibition halls of co-located events (MEDTEC, 3C, Machine Building, Mtec, IPOT, and Practical Vacuum); coffee breaks and luncheon
|
Session 201 - New and Enabling Technologies in Healthcare
|
Chair: Dr Stephen Blatcher BEng CEng PhD, Principle Engineer, Drug Delivery Group, PA Consulting
|
09.15 |
Chair’s Opening Address
|
09.30 |
Biological Medical Devices: Phil Brown, Director, Regulatory Affairs, QA and Reimbursement, Wright Medical Technology
|
10.15 |
New Polymeric Biomaterials with Built-In Surface Modifiers: Robert S. Ward, President/CEO, The Polymer Technology Group
|
11.00 |
Break
|
11.15 |
Enabling Technologies for Future Orthopaedic Surgical Processes: Alan Ashby, Vice-President Global Concept Development, DePuy
|
12.00 |
The Use of RF Technology in Healthcare - Past, Present and Future: Peter Morgan, Managing Consultant, PA Consulting
|
12.45 |
Lunch
|
14.00 |
Imprinted Polymers - A New Medical Material: Professor Anthony P F Turner, Director, Cranfield Ventures, Cranfield University
|
14.45 |
Microelectronics Medical Devices meet Consumer Electronics: Bringing the Economies of Scale of the Semiconductor Industry to Healthcare: Alison Burdett, Director of Technology, Toumaz
|
15.30 |
Break
|
15.45 |
Molecular Imaging: Emerging Concepts and Their Clinical Applications: Professor S Homer-Vanniasinkam, Consultant Vascular Surgeon, The General Infirmary at Leeds & & Professor of Translational Vascular Medicine, University of Bradford
|
16.30 |
Chair’s Closing Address
|
16.45 |
End of Conference
|
|
|
